Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Dec 14, 2020

SELL
$5.41 - $9.45 $11,902 - $20,790
-2,200 Closed
0 $0
Q4 2018

Jan 23, 2019

BUY
$7.88 - $17.98 $17,336 - $39,556
2,200 New
2,200 $22,000

About LogicBio Therapeutics, Inc.


  • Ticker LOGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,962,700
  • Description
  • LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...
More about LOGC
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.